Comprehensive Characterization of Humoral Correlates of Human Immunodeficiency Virus 1 Superinfection Acquisition in High-risk Kenyan Women

[1]  D. Montefiori,et al.  Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk , 2017, Journal of Virology.

[2]  S. Zolla-Pazner,et al.  Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits , 2016, Journal of Virology.

[3]  A. Dingens,et al.  HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and are Commonly Detected in Plasma from HIV-infected Humans , 2015, EBioMedicine.

[4]  H. Liao,et al.  Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1 , 2015, Journal of Virology.

[5]  R. McClelland,et al.  The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection , 2015, PLoS pathogens.

[6]  Haiyan Chen,et al.  Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission. , 2015, The Journal of clinical investigation.

[7]  J. Overbaugh,et al.  Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality. , 2015, Cell host & microbe.

[8]  Jerome H. Kim,et al.  Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses. , 2014, The Journal of infectious diseases.

[9]  R. McClelland,et al.  HIV-1 superinfection is associated with an accelerated viral load increase but has a limited impact on disease progression , 2014, AIDS.

[10]  W. Britt,et al.  Low antibody-dependent cellular cytotoxicity responses in Zambians prior to HIV-1 intrasubtype C superinfection. , 2014, Virology.

[11]  John P. Moore,et al.  A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies , 2013, PLoS pathogens.

[12]  David F. Boyd,et al.  HIV-1 Superinfection Occurs Less Frequently Than Initial Infection in a Cohort of High-Risk Kenyan Women , 2013, PLoS Pathogens.

[13]  T. Quinn,et al.  Frequency and implications of HIV superinfection. , 2013, The Lancet. Infectious diseases.

[14]  Jerome H. Kim,et al.  Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG , 2013, Proceedings of the National Academy of Sciences.

[15]  R. McClelland,et al.  Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection. , 2013, Journal of acquired immune deficiency syndromes.

[16]  P. Hraber,et al.  HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection , 2012, Retrovirology.

[17]  Oliver Laeyendecker,et al.  The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda. , 2012, The Journal of infectious diseases.

[18]  J. Overbaugh,et al.  HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads , 2012, PLoS pathogens.

[19]  Guido Ferrari,et al.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial. , 2012, The New England journal of medicine.

[20]  R. McClelland,et al.  Cellular immune responses and susceptibility to HIV-1 superinfection: a case–control study , 2012, AIDS.

[21]  A. Trkola,et al.  HIV-1 Superinfection in Women Broadens and Strengthens the Neutralizing Antibody Response , 2012, PLoS pathogens.

[22]  L. Morris,et al.  The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection , 2011, Journal of Virology.

[23]  J. Baeten,et al.  Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression , 2009, Journal of Virology.

[24]  C. Blish,et al.  Cross-Subtype Neutralization Sensitivity despite Monoclonal Antibody Resistance among Early Subtype A, C, and D Envelope Variants of Human Immunodeficiency Virus Type 1 , 2009, Journal of Virology.

[25]  Terri Wrin,et al.  Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm , 2009, Journal of Virology.

[26]  B. Chohan,et al.  Human Immunodeficiency Virus Type 1 Superinfection Occurs despite Relatively Robust Neutralizing Antibody Responses , 2008, Journal of Virology.

[27]  Vicki C. Ashley,et al.  Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia , 2008, Journal of Virology.

[28]  B. Chohan,et al.  Examination of a second region of the HIV type 1 genome reveals additional cases of superinfection. , 2008, AIDS research and human retroviruses.

[29]  Anne Piantadosi,et al.  Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection , 2007, PLoS pathogens.

[30]  J. Overbaugh,et al.  A TRIM5alpha-independent post-entry restriction to HIV-1 infection of macaque cells that is dependent on the path of entry. , 2007, Virology.

[31]  C. Blish,et al.  HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry , 2007, AIDS.

[32]  D. Richman,et al.  Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. , 2006, Virology.

[33]  Feng Gao,et al.  Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa , 2006, Journal of Virology.

[34]  D. Venzon,et al.  A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. , 2006, Journal of immunological methods.

[35]  Bhavna Chohan,et al.  Evidence for Frequent Reinfection with Human Immunodeficiency Virus Type 1 of a Different Subtype , 2005, Journal of Virology.

[36]  D. Richman,et al.  Incidence of HIV superinfection following primary infection. , 2004, JAMA.

[37]  Todd M. Allen,et al.  HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus , 2002, Nature.

[38]  J. Overbaugh,et al.  HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus. , 2002, AIDS research and human retroviruses.

[39]  B. Richardson,et al.  Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. , 1998, The Journal of infectious diseases.